← Back to Discover
Elmind Capital, LP
Period ended Sep 30, 2026 · Latest filing Nov 16, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $403,836,290
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $35,975,100
- LEGEND BIOTECH CORP · SPONSORED ADS · 52490G102 · shares: $31,220,856
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $30,174,000
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $27,753,079
- RELAY THERAPEUTICS INC · COM · 75943R102 · shares: $26,448,286
- AMYLYX PHARMACEUTICALS INC · COM · 03237H101 · shares: $26,037,516
- VIRIDIAN THERAPEUTICS INC · COM · 92790C104 · shares: $25,221,329
- VAXCYTE INC · COM · 92243G108 · shares: $21,186,146
- UROGEN PHARMA LTD · COM · M96088105 · shares: $19,953,393
- TRAVERE THERAPEUTICS INC · COM · 89422G107 · shares: $18,994,688
Reported holdings
30 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 1,110,000 shares | $35,975,100 |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | — | 1,569,676 shares | $31,220,856 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 1,605,000 shares | $30,174,000 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 866,742 shares | $27,753,079 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 1,465,279 shares | $26,448,286 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 894,760 shares | $26,037,516 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 1,224,931 shares | $25,221,329 |
| VAXCYTE INC | COM | 92243G108 | — | 372,340 shares | $21,186,146 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 491,100 shares | $19,953,393 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 322,600 shares | $18,994,688 |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | — | 962,792 shares | $14,778,857 |
| PHARVARIS N V | COM | N69605108 | — | 455,750 shares | $14,456,390 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 436,518 shares | $14,095,166 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 4,550,000 shares | $12,376,000 |
| BEAM THERAPEUTICS INC | COM | 07373V105 | — | 476,338 shares | $11,646,464 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 460,000 shares | $10,906,600 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 493,820 shares | $8,350,496 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 15,000 shares | $8,128,350 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 256,143 shares | $7,758,571 |
| KRYSTAL BIOTECH INC | COM | 501147102 | — | 22,000 shares | $7,316,320 |
| ALUMIS INC | COM | 022307102 | — | 749,560 shares | $5,539,248 |
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | — | 520,000 shares | $4,331,600 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 228,265 shares | $3,677,349 |
| MBX BIOSCIENCES INC | COM | 55287L101 | — | 61,000 shares | $3,575,820 |
| DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | — | 265,000 shares | $3,116,400 |
| SUPERNUS PHARMACEUTICALS | COM | 868459108 | — | 70,000 shares | $3,012,800 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 47,000 shares | $2,820,000 |
| SEPTERNA INC | COM | 81734D104 | — | 49,444 shares | $1,934,744 |
| ALECTOR INC | COM | 014442107 | — | 915,902 shares | $1,694,419 |
| DESIGN THERAPEUTICS INC | COM | 25056L103 | — | 107,900 shares | $1,356,303 |